| Patent application number | Description | Published |
|---|
| 20080214950 | PROSTATE CANCER DETECTION APPARATUS - A prostrate cancer detection apparatus has a measurement sensor for detection of at least one prostate cancer-specific biomarker, an evaluation unit for determination of at least one risk value from at least one prostate cancer-specific biomarker detected by the measurement sensor, and a display unit to display the at least one determined risk value. | 09-04-2008 |
| 20080275341 | Device for X-Ray Brachytherapy, and Method for Positioning a Probe Introduced Into a Body for X-Ray Brachytherapy - In a system and method for x-ray brachytherapy, a probe is introduced into the body of a subject, the probe carrying an x-ray source that radiates x-rays into an exposure area outside of the probe within the body of the subject. A number of markers are located in or on the probe, that are detectable in an image generated by an imaging device. The markers are located in or on the probe in a known spatial relation to the exposure area, so that the position of the exposure area can be determined by identifying the markers in the displayed image. | 11-06-2008 |
| 20080298548 | Device for X-Ray Brachytherapy, and Method for Positioning a Probe Introduced Into a Body for X-Ray Brachytherapy - In a method and device for x-ray brachytherapy, a probe is inserted into and moved within a living subject, the probe having a distal end, an x-ray source carried by said probe at said distal end that irradiates an x-ray beam into an exposure area outside of the probe, a mark generator carried by said probe at said distal end that generates a mark that identifies at least a portion of said exposure area, and an optical observation system, having an optical detector carried at said distal of said probe, that generates an optical image of said at least one part of said exposure area that is identified by said marking, the marking being visible in said optical image. | 12-04-2008 |
| 20090060842 | METHOD FOR DIAGNOSIS AND TREATMENT OF PROSTATITIS - In a method for diagnosis and treatment of a patient with regard to prostatitis, a differential diagnosis of prostatitis versus prostate cancer and/or BPH is conducted on a patient using a cost-effective diagnosis method. Given diagnosed prostatitis, a cost-effective decision test is implemented on the patient to determine whether the patient exhibits complaints locally in the region of the prostate or in the rest of the body. A molecular inflammation marker is administered to the patient, wherein a cost-effective imaging method is implemented in the region of the prostate of the patient given local complaints or a cost-intensive imaging method is implemented on the entire patient given complaints in the rest of the body. An inflammation-inhibiting treatment is implemented in the body region of the patient that is detected as inflamed via the respective imaging method. | 03-05-2009 |
| 20090060844 | METHOD AND CONTRAST AGENT FOR IMAGING A PROSTATE TUMOR - In a method for imaging a prostate tumor in which a contrast agent that can be distributed via the circulatory system is administered to the patient, the contrast agent contains at least one type of biomarkers which are bound to a ferromagnetic particle and specifically bind to a target molecule typical of the tumor and formed within the tumor or in a tissue adjacent to the tumor. The imaging ensues with the use of magnetic resonance tomography. | 03-05-2009 |
| 20090060845 | DIAGNOSIS SUBSTANCE FOR APPLICATION IN A METHOD TO DIAGNOSIS PATHOLOGICAL TISSUE AND A METHOD FOR PRODUCTION OF SUCH A DIAGNOSIS SUBSTANCE - A diagnosis substance for application in a method for diagnosis of pathological tissue, contains at least one virus population with virus particles specifically binding to target molecules typical of a specific pathological tissue, with a label that is detectable with the use of a detection device being bound to the virus particles. In a method for production of such a diagnosis substance, the principle of directed biological evolution is applied. | 03-05-2009 |
| 20090060847 | CONTRAST AGENT FOR ULTRASOUND EXAMINATION OF THE PROSTATE AND METHOD TO DIAGNOSE PROSTATE CANCER - A contrast agent for ultrasound examination of the prostate has contrast-intensifying particles on an exterior of which at least one binding molecule is present that specifically binds to CEACAM-1. In a method for ultrasound examination of the prostate, such a contrast agent is administered to the patient and a sonography of the prostate is subsequently implemented. | 03-05-2009 |
| 20090060926 | MEDICINE FOR TREATMENT OF CARCINOMA - A medicine for treatment of a carcinoma which can be supplied to the carcinoma via the circulatory system, contains two active components coupled to one another. The first active component is formed of at least one coupling molecule that specifically tethers to a target molecule formed by the cancer tissue. The second active component is formed of at least one signal molecule typical to inflammation, or of at least originating molecule encoding such a signal molecule. | 03-05-2009 |
| 20090062645 | METHOD FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER - In a method for diagnosis and treatment of a patient with a tumor relating to prostate cancer, the following steps are implemented. A differential diagnosis of prostate cancer versus prostatitis and/or BPH is conducted on a patient using a cost-effective diagnosis method. If prostate cancer is diagnosed in the patient using a cost-effective measurement method, a characteristic value for the tumor aggressiveness of the prostate cancer is determined. A watchful waiting treatment is implemented with the patient given a characteristic value below a predeterminable first limit value. The size and position of the tumor is determined using a cost-effective method given a characteristic value above the first limit value. A cost-effective ultrasonic theranosis or a conventional therapy is conducted for a size below a second predeterminable limit value. The presence of metastases in the patient is checked, with a cost-intensive method generating image information, for a size above the second limit value. A metastasis treatment is implemented in the event that metastases are present. In the event that no metastases are present, a tumor treatment based on the aforementioned image information generated is implemented. | 03-05-2009 |
| 20090087384 | MEDICINE AND METHOD FOR TREATMENT OF PROSTATE CANCER - The invention concerns a medicine for treatment of prostate cancer and a corresponding treatment method. The medicine can be supplied to a prostate tumor through the bloodstream, contains an active component and a binding component as well as ultrasound microbubbles. The binding component includes coupling molecules that specifically bind to a determined target molecule formed in the endothelium of tumor-associated blood vessels and that is typical of the tumor or the tumor stage. The active component contains at least one chemotherapeutic substance. The coupling molecules are bound to the outside of the microbubbles and active substance molecules are likewise bound to the outside of the microbubbles or are enclosed by the microbubbles. | 04-02-2009 |
| 20090131789 | DEVICE FOR X-RAY BRACHYTHERAPY, AND METHOD FOR POSITIONING A PROBE INTRODUCED INTO A BODY FOR X-RAY BRACHYTHERAPY - In a method and a device for x-ray brachytherapy, a probe is inserted into the interior of the body of a subject, the probe carrying at its distal end an x-ray source that radiates x-rays into an exposure area in the body of the subject outside of the probe. The probe also contains an x-ray array that generates an ultrasound image representing at least a portion of the exposure area. A display device displays the ultrasound image to allow identification of the exposure area in the ultrasound image. | 05-21-2009 |
| 20090180586 | UROLOGICAL X-RAY WORKSTATION WITH ORBITING X-RAY IMAGING COMPONENTS - A urological x-ray workstation has an x-ray source and an x-ray receiver that are respectively supported on device retainers of a device carrier located at the longitudinal side of a patient positioning table such that they can be positioned opposite one another and independently of one another in various positions on an orbit proceeding around a common center in a working plane oriented perpendicular to the longitudinal axis. | 07-16-2009 |
| 20100022912 | METHOD AND APPARATUS TO DETERMINE A PARAMETER PERTAINING TO THE PROSTATE OF A PATIENT - In a method to determine at least one parameter pertaining to a prostate of a patient, an integrated diagnostic support system implements the following steps. A first risk value for prostate illness is determined using a screening method. In the event that this first characteristic risk value exceeds a first limit value, at least one second characteristic risk value for prostate illness and its location are determined using a method supplying a medical image of the patient. An integrated report system outputs at least one of the characteristic risk values and/or the location. A corresponding device has a mini-laboratory analysis unit for the screening test, an intelligent decision support system for the first characteristic risk value, a first interface with an imaging system, an evaluation system for the medical image for the second characteristic risk value, and a report system with a user interface. | 01-28-2010 |
| 20100189659 | DIAGNOSTIC SUBSTANCE AND METHOD FOR THE DIAGNOSIS OF PROSTATE DISEASES - A diagnostic substance for use in a method for diagnosing prostate diseases contains multiple different coupling molecules that respectively bind to signal molecules (target molecules) of a molecular surface structure of a pathological tissue that is associated with a prostate disease. A first of the coupling molecules specifically binds to signal molecules of cancer tissue, and a second of the coupling molecules specifically binds to signal molecules formed in inflamed tissue. First and second markers are respectively associated with the first and second coupling molecules, the first and second markers being detectable, and differentiated from each other, with a detection device. | 07-29-2010 |
| 20100240993 | METHOD AND MEDICAL APPARATUS FOR DETERMINING A TUMOR CHARACTERISTIC - In a method and medical apparatus to determine a tumor characteristic related to a body region of a patient, the body region is exposed to acoustic energy that mechanically irritates the body region. A first value of a characteristic value of the patient that is correlated with the irritation is determined at a first point in time. A second value of the characteristic value is determined at a second point in time after the first point in time and after the exposure. The tumor characteristic is determined from the change between first value and second value. | 09-23-2010 |
| 20100286517 | System and Method For Image Guided Prostate Cancer Needle Biopsy - In a method for image guided prostate cancer needle biopsy, a first registration is performed to match a first image of a prostate to a second image of the prostate. Third images of the prostate are acquired and compounded into a three-dimensional (3D) image. The prostate in the compounded 3D image is segmented to show its border. A second registration and then a third registration different from the second registration is performed on distance maps generated from the prostate borders of the first image and the compounded 3D image, wherein the first and second registrations are based on a biomechanical property of the prostate. A region of interest in the first image is mapped to the compounded 3D image or a fourth image of the prostate acquired with the second modality. | 11-11-2010 |
| 20110223109 | DIAGNOSTIC SUBSTANCE FOR USE IN A METHOD FOR DETERMINING THE AGGRESSIVENESS OF A PROSTATE TUMOR AND DIAGNOSTIC METHOD - In order to determine the aggressiveness of a prostate tumor, a diagnostic substance is administered to a patient that includes a biomarker provided with a first label that is detectable with a detection device and that specifically binds to a VEGF molecule, and that contains a biomarker that binds specifically to a target molecule that occurs uniformly in the endothelium of blood vessels of healthy tissue and the blood vessels of a prostate tumor, and that is provided with a second label that is detectable with the detection device independently of the first label. | 09-15-2011 |
| 20110230752 | SCREENING TEST FOR RECOGNIZING PROSTATE DISEASES AND APPARATUS AND DIAGNOSIS SUBSTANCE FOR CARRYING OUT THE TEST - In a screening test method, and a device for implementing the screening test method, a diagnostic substance is provided that contains at least one biomarker connected with at least one ferromagnetic particle, the biomarker binding specifically to a target molecule that is formed by specific pathological prostrate tissue. The diagnostic substance is administered to the blood stream of a patient. A magnetometer is used to detect enrichment of the ferromagnetic particle in the prostrate, as an indicator of a level of the specific pathological prostrate tissue. | 09-22-2011 |
| 20120082732 | MEDICINE FOR TREATMENT OF A CARCINOMA - In a method for treating a carcinoma in a patient, a medicine is administered via the blood stream of the patient that appears, to the patient's immune system, that tissue of the carcinoma is an inflammation source. The medicine employs two active components that are coupled to each other in a form allowing administration of the two active components to the carcinoma via the blood stream of the patient. A first of the active components is at least one coupling molecule that specifically tethers to a target molecule formed by cancer tissue of the carcinoma. A second of the active ingredients is at least one signal molecule typical to inflammation, or at least one originating molecule encoding such a signal molecule, that induces the immune system of the body to attack the cancer cells. | 04-05-2012 |
| 20120252057 | METHOD AND DEVICE FOR DETECTING TUMOROUS LIVING CELL TISSUE - The invention relates to a method and to an apparatus for recognizing tumorous living cell tissue. It furthermore relates to a method and to an apparatus for recognizing tumorous cell tissue at collected living cell tissue samples. In the method, electromagnetic radiation is emitted with local definition onto cell tissue by a radiation source and, after deactivation of the radiation source, the decay behavior of the inherent fluorescence intensity of the cell tissue excited by the electromagnetic radiation is detected at the cell tissue in a time resolved and spectrally resolved manner at known sampling rate(s) for at least one wavelength using a detector. The difference autocorrelation function C(t) of the intensity decay behavior is determined using the determined measured intensity values, the fractal dimension D | 10-04-2012 |
| 20130096438 | METHOD AND DEVICE FOR DETECTING TUMOROUS TISSUE IN THE GASTROINTESTINAL TRACT WITH THE AID OF AN ENDOCAPSULE - In a method and apparatus for detecting tumorous cell tissue in a gastrointestinal tract, electromagnetic radiation is emitted in a locally defined manner from an endoscope onto cell tissue and, after deactivation of the radiation, the decay of the inherent fluorescence intensity of the irradiated cell tissue, excited by the electromagnetic radiation, is detected, with temporal and spectral resolution and with a known scanning rate for at least one wavelength. From the intensity measurement values obtained in this manner, the difference autocorrelation function of the intensity decay is determined, from which a fractal dimension for the irradiated cell tissue is determined. The value of the fractal dimension is used to classify the irradiated cell tissue as to a degree to which the cell tissue is tumorous. | 04-18-2013 |
| 20130253485 | MEDICAL EXAMINATION SYSTEM - A system includes at least one device that includes at least one device component. For a defined movement of the at least one device component, a movement axis and/or a movement direction may be selected by a selection element and may be identified by an activatable lighting element. The identified movement axis and/or the identified movement direction may be released by at least one actuation element, so that a desired movement of the at least one device component may be performed. | 09-26-2013 |
| 20140016741 | DEVICE AND METHOD FOR A DIAGNOSTIC APPARATUS - In this device and the associated method, a connection unit that can be attached to an arm bearing an x-ray source and an x-ray receiver is fashioned such that said connection unit compensates for a pivot movement of the arm so that a compression unit arranged at the connection unit remains stationary during a pivot movement. | 01-16-2014 |
| 20150031986 | MEDICAL INSTRUMENT FOR USE WITH A PHASE CONTRAST IMAGING AND X-RAY RECORDING SYSTEM WITH PHASE CONTRAST IMAGING - A medical instrument is provided for use with a phase contrast imaging. The medical instrument includes at least one component, which has a strong small angle scattering of x-rays. Furthermore, a corresponding x-ray recording system with phase contrast imaging for recording an examination object may include such a medical instrument. | 01-29-2015 |
| 20150036796 | MAMMOGRAPHY APPARATUS - In a mammography apparatus, a deflection of an x-ray source aligned on a radiation detector is predetermined depending on the size of a breast compressed in the compression unit and/or the density of the breast tissue. Given an increasing deflection on an arc-shaped trajectory of the x-ray source, the compression of the breast is reduced at least once so that the path of the x-rays through the breast stays within a predetermined path length, starting from a first compression in a first x-ray acquisition. | 02-05-2015 |
